NewsRoom Articles - Page 127 of 154 - PsychedelicNewsWire (PNW)

FridayJul 10, 2020 3:00 pm

The 3 Types of Responses to Psychedelics

Scientific research shows that psychedelics affect the part of the brain connected with how a person visualizes things, feels, or the mood. It's believed that psychedelics affect serotonin, a neurotransmitter. This is the main reason why most people who ingest it notice changes in perception, emotion, and cognition. Also worth noting is the physiological responses that a user may feel that may cause stress and panic, a situation commonly referred to as a 'bad trip.' The effect of psychedelics depends on the type of substance. For instance, psilocybin’s general effects differ from those of LSD. The impacts can be short-term…

FridayJul 10, 2020 10:00 am

Hawaii Legislature Considers Legalizing Magic Mushrooms

Hawaii has joined other jurisdictions in the exploration of psilocybin (commonly known as Magic Mushrooms) as an antidepressant. Two Hawaii legislators recently proposed measures that could see psilocybin products become legal. The plan seeks to explore these psychedelics mushrooms to determine their health benefits. This is not the first time that someone has called for the legalization of psychedelics. Other U.S. states have also shown interest in testing the effectiveness of psychedelic substances and the first research clinic in New York City was opened. If the Hawaii lawmakers are successful, psilocybin products will be approved for medical use. Rep. Chris…

ThursdayJul 09, 2020 3:00 pm

4 Tips for Psychedelic-Assisted Therapy of Native American Patients

As more clinics get licensed around the U.S. to use psychedelic-assisted therapy to treat patients suffering from a variety conditions, it is important to understand the culture of each patient’s community so that the treatment sessions can be tweaked to align with crucial cultural factors. In this post, we look at some peculiarities of Native Americans that therapists need to keep in mind during treatment sessions. Trust and Respect Matter a Lot Throughout history, the relations between the outside community and Native Americans has been characterized by distrust and deceit. Consequently, Native Americans tend to be wary of people who…

ThursdayJul 09, 2020 10:00 am

US Doctor Requests Temporary FDA Approval of Psychedelics to Fight Covid-19 Related Trauma

As COVID-19 continues to wreak havoc globally, it seems medics may have to turn to psychedelics to help deal with the anxiety and depression triggered by the pandemic. Psychedelic-based medications currently feature three major substances; MDMA, LSD, and Psilocybin, commonly referred to as Magic Mushrooms. Psychedelics are yet to be legalized worldwide because of the stigma attached to the 'drug.' The good news is that clinical studies are providing accurate data about these substances, and are revealing how effective they are when administered under medical supervision. U.S. psychiatrist Dr. Morgan Campbell recently brought the matter to light while addressing the…

WednesdayJul 08, 2020 2:00 pm

COVID-19 Likely to Give Psychedelics a Boost

Pharmacists are proposing psychedelics therapy as a measure to deal with the mental health issues caused by the COVID-19 pandemic. Previous experience with 2003’s SARS (severe acute respiratory syndrome) revealed the overwhelming trauma that such a pandemic can cause. It’s projected that the COVID-19 pandemic will have similar or worse cases of post-traumatic stress disorder. Considering many have lost loved ones, jobs, homes, disruption of learning, separation, and so much more, it is likely to take a huge toll on people. Cases of suicides, addiction, stress, and depression may be on the rise. Dr. Morgan Campbell, a psychiatrist from Wisconsin,…

WednesdayJul 08, 2020 10:56 am

Pure Extract Technologies Inc. Set to Become Dominant Extraction Company in Growing Mushroom Space

Functional mushrooms seeing rise in popularity due to health benefits, alternative medicine options Predictions show global medicinal mushroom market growing annually by $13.88 billion Pure Extracts is ideally positioned to enter the space as experienced producer Used for centuries for their impressive medicinal properties and health benefits, functional mushrooms are enjoying a rise in popularity, due at least in part to increased research and study of the natural fungi as well as trends toward alternative natural health options. Pure Extract Technologies, a private, plant-based extraction company with a new vertical in functional mushrooms, is focused on becoming the dominant extraction…

WednesdayJul 08, 2020 10:00 am

How Psychedelics Could End the Opioid Pandemic

Due to the ongoing global spread of the novel coronavirus, some ailments have been ignored as potential threats to global health. One of these is the widespread opioid epidemic in the U.S. Purdue Pharma is a pharmaceutical company, currently run by the Sackler family, which many say has contributed a lot to the opioid epidemic running across the U.S. Purdue Pharma is believed to have played a big role in the making of the killer Oxycotin. Opioids were initially given a suspicious clean bill of health by numerous doctors and scientists who claimed that they were not addictive. This approval…

TuesdayJul 07, 2020 4:00 pm

Military Puts $27M into Developing Psychedelic-Based Medicines

One of the biggest health challenges affecting the modern world is depression and substance addiction. The treatments for these conditions vary, but almost always end up in prescription pills. The U.S. military seems determined to change this, according to reports reaching media houses. Over the years, people have visited therapists and psychiatrists seeking help due to depression, anxiety, stress, and PTSD (post-traumatic stress disorder), and doctors prescribe drugs to help them with these situations. Of recent, governmental departments, one being DARPA (Defense Advanced Research Projects Agency), have started investing in researching for a new class of drugs that will enhance…

TuesdayJul 07, 2020 3:04 pm

Cybin Corp. is “One to Watch”

Cybin is a leading Canada-based mushroom life sciences company focused on psychedelic medicines and nutraceutical products The company has two operating divisions – Serenity Life Sciences (psychedelic pharmaceutical products) and Natures Journey Inc. (medicinal nutraceutical products) Members of Cybin’s experienced management team have collectively run multiple clinical trials and helped facilitate over $1 billion in pharmaceutical sales The company recently announced a strategic partnership with the Toronto Centre for Psychedelic Science Cybin is currently marketing a range of fungi-based supplements under its Journey brand aimed at breaking into the global non-psychedelic legal supplement market, which is valued at $25 billion…

TuesdayJul 07, 2020 10:00 am

Clinical Trial on Treating Cluster Headaches Using LSD Underway

A Phase 2 clinical trial on how LSD can be used to treat cluster headaches is underway in Switzerland. The trial is being conducted at Liechti Lab at University Hospital Basel. Patients willing to participate in this study were recruited in January this year and the trial is now underway. Cluster headaches are also referred to as “suicide headaches” since the pain they cause is so severe that many patients with this condition develop suicidal tendencies during an episode. Cluster headaches have also been variously described as the most painful condition that anyone can ever suffer from. The pain caused…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000